These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23240829)
1. The utility of staging in canine mast cell tumours. Warland J; Amores-Fuster I; Newbury W; Brearley M; Dobson J Vet Comp Oncol; 2014 Dec; 12(4):287-98. PubMed ID: 23240829 [TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound for sentinel lymph node mapping in the routine staging of canine mast cell tumours: A feasibility study. Fournier Q; Thierry F; Longo M; Malbon A; Cazzini P; Bisson J; Woods S; Liuti T; Bavcar S Vet Comp Oncol; 2021 Sep; 19(3):451-462. PubMed ID: 32840038 [TBL] [Abstract][Full Text] [Related]
3. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Worley DR Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227 [TBL] [Abstract][Full Text] [Related]
5. Ultrasound is a poor predictor of early or overt liver or spleen metastasis in dogs with high-risk mast cell tumours. Pecceu E; Serra Varela JC; Handel I; Piccinelli C; Milne E; Lawrence J Vet Comp Oncol; 2020 Sep; 18(3):389-401. PubMed ID: 31863546 [TBL] [Abstract][Full Text] [Related]
6. Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats. Herring ES; Smith MM; Robertson JL J Vet Dent; 2002 Sep; 19(3):122-6. PubMed ID: 12382529 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the utility of lymph node fine-needle aspiration cytology for the staging of malignant solid tumors in dogs. Fournier Q; Cazzini P; Bavcar S; Pecceu E; Ballber C; Elders R Vet Clin Pathol; 2018 Sep; 47(3):489-500. PubMed ID: 30011068 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone marrow aspirates from multiple sites for staging of canine lymphoma and mast cell tumours. Aubry OA; Spangler EA; Schleis SE; Smith AN Vet Comp Oncol; 2014 Mar; 12(1):58-66. PubMed ID: 22577893 [TBL] [Abstract][Full Text] [Related]
9. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
10. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery. Marconato L; Stefanello D; Kiupel M; Finotello R; Polton G; Massari F; Ferrari R; Agnoli C; Capitani O; Giudice C; Aresu L; Vasconi ME; Rigillo A; Sabattini S Vet Comp Oncol; 2020 Sep; 18(3):409-415. PubMed ID: 31930651 [TBL] [Abstract][Full Text] [Related]
12. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours. Moore AS; Frimberger AE; Taylor D; Sullivan N Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). Baginski H; Davis G; Bastian RP J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400 [TBL] [Abstract][Full Text] [Related]
15. Abdominal CT evaluation of the liver and spleen for staging mast cell tumors in dogs yields nonspecific results. Hughes JR; Szladovits B; Drees R Vet Radiol Ultrasound; 2019 May; 60(3):306-315. PubMed ID: 30786323 [TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas. Lee BM; Clarke D; Watson M; Laver T Vet Comp Oncol; 2020 Dec; 18(4):590-598. PubMed ID: 32115867 [TBL] [Abstract][Full Text] [Related]
17. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. Weishaar KM; Thamm DH; Worley DR; Kamstock DA J Comp Pathol; 2014 Nov; 151(4):329-38. PubMed ID: 25172053 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours. Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226 [TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926 [TBL] [Abstract][Full Text] [Related]
20. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Ferrari R; Marconato L; Buracco P; Boracchi P; Giudice C; Iussich S; Grieco V; Chiti LE; Favretto E; Stefanello D Vet Comp Oncol; 2018 Dec; 16(4):505-510. PubMed ID: 29893066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]